Q&As

MPE has developed a series of Q&As for patients and patient advocates, covering the main issues regarding treatment updates and advocacy relevant topics. Check the following factsheets on:

 

• EU funded projects
• SARS-CoV-2 (COVID-19) Vaccination and Treatment
• Chimeric Antigen Receptor T cell (CAR-T) therapy
• SARS-CoV-2 (COVID-19) Vaccination for Myeloma Patients
• COVID-19 (coronavirus) and myeloma and AL amyloidosis treatment
• Health technology assessment (HTA)
• H2020 MMPredict